Pharma and NICE must end games of ‘one-upmanship’
November 10, 2008Sales and Marketing NHS, par
Patient groups are calling on a pharmaceutical company to reach a compromise with NICE over a bone marrow cancer drug. …
Working Life: Viggo Birch
November 10, 2008Business Services, Research and Development, Sales and Marketing Novo Nordisk, WL, careers
How did you arrive at your current position?A long story. I started in Mobil Oil in Denmark after graduating from …
Latest news from Datamonitor
November 10, 2008Research and Development, Sales and Marketing HRT
Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …
Emerging markets shine for AstraZeneca
November 6, 2008Sales and Marketing AZ, China, hc
AstraZeneca saw overall sales for the three months to September rise 3% to $7.8 billion. But growth in emerging markets …
Major economies facing recession
November 6, 2008Sales and Marketing hc
The UK, US and Japan must brace themselves for a full year of recession in 2009, according to economists. The …
Healthcare challenges ahead for Obama
November 6, 2008Sales and Marketing US, reform
After his resounding election victory, America's new President-Elect Barack Obama is already assembling his White House team. During the election, …
NICE to collect its own patient data
November 6, 2008Sales and Marketing NICE
NICE's chairman Prof Sir Michael Rawlins has revealed some details of how it will change to ensure more patients will …
Medicine top-ups to be allowed
November 5, 2008Sales and Marketing NICE, par
The ban on NHS patients using top-up payments to receive privately-prescribed medicines has been lifted in a move aimed at …
The best two things to happen to pharma?
November 5, 2008Sales and Marketing NHS, health checks, healthcare
Bayer’s ‘revolutionary’ anticoagulant Xarelto launched
November 4, 2008Sales and Marketing Xarelto
Xarelto, the new anticoagulant treatment from Bayer has been launched in the UK, and is set to be among a …
The rise and rise of the interim manager
November 3, 2008Business Services interim management, recruitment
Interim management is now a popular choice in pharma marketing, both for companies looking to recruit for short spells, and …
Latest news from Datamonitor
November 3, 2008Sales and Marketing Acomplia, Sanofi
Acomplia's EU suspension dispels illusion of blockbuster futureThe EMEA has suspended Acomplia due to the risk of serious psychiatric disorders. …
Call for more not-for-profit healthcare providers
October 30, 2008Sales and Marketing NHS, hc
Healthcare provision should increasingly be modelled along social enterprise lines, according to the NHS Alliance. Not-for-profit groups of out-of-hours providers …
Contraceptive and Betaferon sales bolster Bayer
October 30, 2008Sales and Marketing Bayer
Strong sales of Bayer's Yaz contraceptives and multiple sclerosis treatment Betaferon have helped third quarter pharma sales that could only …
Study boost for Roche’s Actemra
October 30, 2008Research and Development, Sales and Marketing RA, Roche
New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …
Alzheimer’s companies hope renewed by House of Lords
October 30, 2008Sales and Marketing Alzheimer's, NICE
The companies behind Alzheimer's drug Aricept have won the right to see the economic model NICE used to assess the …
Strong results for Novartis drug in rare autoimmune disease
October 30, 2008Research and Development, Sales and Marketing Novartis
Novartis' development drug ACZ885 (canakinumab) has turned in impressive results in trials for rare medical conditions. It showed sustained remission …
GSK to acquire Hepatitis C specialists Genelabs
October 30, 2008Sales and Marketing GSK, Genelabs, MA
GlaxoSmithKline is to pay $57 million (£35 million) for Genelabs, California-based specialists in infectious diseases, including hepatitis C. The companies …
Specialising for success
October 29, 2008Research and Development, Sales and Marketing marketing, product portfolio
From the middle of the last century, the likes of GSK, Pfizer, AstraZeneca, Bristol Myers Squibb and others have made …
Working Life: Philip Sarbutt
October 28, 2008Research and Development, Sales and Marketing UK, Wyeth, Wyeth Pharmaceuticals, outsourcing
How did you find your way into your role?
